As the SELECT trial nears completion, a similar large trial was launched in autumn 2022, but this one involves a new wrinkle on GLP-1 receptor agonism that appears to yield even greater weight loss
Health Disclaimer: ColonBroom GLP-1 Booster is a dietary supplement, not a medical treatment or prescription drug
It is crucial to understand that microdosing is not a licensed or evidence-based approach to GLP-1 therapy
The number of lean patients was too few to make any definitive conclusion
For example, Ozempic may be kept at room temperature (up to 86F/30C) for 56 days after first use, while Victoza and Saxenda allow 30 days at room temperature
Popular GLP-1 medications include: Semaglutide (Ozempic, Wegovy) Liraglutide (Victoza, Saxenda) Tirzepatide (Mounjaro, Zepbound) Dulaglutide (Trulicity) Exenatide (Byetta) These medications were first approved to treat type 2 diabetes but are now also used to help people with obesity lose weight